Investigational Drug Information for Fosmidomycin
✉ Email this page to a colleague
What is the drug development status for Fosmidomycin?
Fosmidomycin is an investigational drug.
There have been 7 clinical trials for Fosmidomycin.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2005.
The most common disease conditions in clinical trials are Malaria, Malaria, Falciparum, and [disabled in preview]. The leading clinical trial sponsors are Jomaa Pharma GmbH, Albert Schweitzer Hospital, and Mahidol University.
Summary for Fosmidomycin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 316 |
| WIPO Patent Applications | 233 |
| Japanese Patent Applications | 77 |
| Clinical Trial Progress | Phase 3 (2005-06-01) |
| Vendors | 26 |
Recent Clinical Trials for Fosmidomycin
| Title | Sponsor | Phase |
|---|---|---|
| Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria | Centre de Recherche Médicale de Lambaréné | Phase 2 |
| Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria | Jomaa Pharma GmbH | Phase 2 |
| Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria | Albert Schweitzer Hospital | Phase 2 |
Clinical Trial Summary for Fosmidomycin
Top disease conditions for Fosmidomycin
Top clinical trial sponsors for Fosmidomycin
US Patents for Fosmidomycin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
